FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052416034> ?p ?o ?g. }

• W2052416034 endingPage "1775" @default.
• W2052416034 startingPage "1770" @default.
• W2052416034 abstract "It is now clear that angiogenesis and angiogenesis factors are important in the pathogenesis of haematological malignancies. High pretreatment levels of serum basic fibroblast growth factor have been shown to be associated with poor prognosis in patients with non-Hodgkin's lymphoma. The aim of this study was to evaluate whether non-Hodgkin's lymphoma cells express basic fibroblast growth factor and/or its receptor (fibroblast growth factor receptor-1) and whether basic fibroblast growth factor expression correlates with basic fibroblast growth factor serum levels, intratumoral microvessel density, and patient outcome. We measured basic fibroblast growth factor by enzyme-linked immunosorbent assay in sera taken from 58 patients with non-Hodgkin's lymphoma before treatment and in 19 of them also after treatment. Pathological specimens at diagnosis were evaluated by immunohistochemistry staining using polyoclonal antibody against factor-VIII-related antigen, basic fibroblast growth factor and fibroblast growth factor receptor-1 to determine the expression of the microvessel count and basic fibroblast growth factor and fibroblast growth factor receptor-1. The lymphoma specimens demonstrated positive staining for basic fibroblast growth factor (in 23%) and fibroblast growth factor receptor-1 (in 58.5%). The patients who expressed basic fibroblast growth factor had a significantly worse progression-free and overall survival than those who did not (P=0.003 and P=0.03 respectively), while patients expressing fibroblast growth factor receptor-1 were less likely to achieve complete remission than those lacking the receptor (33% vs 65%, P=0.047). There was no correlation of basic fibroblast growth factor staining with either serum basic fibroblast growth factor levels or microvessel count. Basic fibroblast growth factor serum levels did not change significantly after treatment These results suggest that non-Hodgkin's lymphoma specimens express basic fibroblast growth factor and its receptor (fibroblast growth factor receptor-1) and this expression is associated with poor patient outcome." @default.
• W2052416034 created "2016-06-24" @default.
• W2052416034 creator A5003137410 @default.
• W2052416034 creator A5004594453 @default.
• W2052416034 creator A5009100151 @default.
• W2052416034 creator A5047943045 @default.
• W2052416034 creator A5059360959 @default.
• W2052416034 creator A5081632497 @default.
• W2052416034 creator A5083119424 @default.
• W2052416034 date "2002-06-01" @default.
• W2052416034 modified "2023-10-09" @default.
• W2052416034 title "Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma" @default.
• W2052416034 cites W1575383930 @default.
• W2052416034 cites W1854803455 @default.
• W2052416034 cites W1918337600 @default.
• W2052416034 cites W1995567710 @default.
• W2052416034 cites W2002238276 @default.
• W2052416034 cites W2005435360 @default.
• W2052416034 cites W2031237999 @default.
• W2052416034 cites W2035836783 @default.
• W2052416034 cites W2064964732 @default.
• W2052416034 cites W2066775791 @default.
• W2052416034 cites W2088301689 @default.
• W2052416034 cites W2106054588 @default.
• W2052416034 cites W2117291755 @default.
• W2052416034 cites W2133259751 @default.
• W2052416034 cites W2140242635 @default.
• W2052416034 cites W2158743409 @default.
• W2052416034 cites W2159679541 @default.
• W2052416034 cites W2162454543 @default.
• W2052416034 cites W2291615309 @default.
• W2052416034 cites W2294287567 @default.
• W2052416034 cites W2999700545 @default.
• W2052416034 cites W31979510 @default.
• W2052416034 cites W4205736005 @default.
• W2052416034 doi "https://doi.org/10.1038/sj.bjc.6600330" @default.
• W2052416034 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2375415" @default.
• W2052416034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12087465" @default.
• W2052416034 hasPublicationYear "2002" @default.
• W2052416034 type Work @default.
• W2052416034 sameAs 2052416034 @default.
• W2052416034 citedByCount "25" @default.
• W2052416034 countsByYear W20524160342013 @default.
• W2052416034 countsByYear W20524160342014 @default.
• W2052416034 countsByYear W20524160342016 @default.
• W2052416034 countsByYear W20524160342019 @default.
• W2052416034 countsByYear W20524160342021 @default.
• W2052416034 countsByYear W20524160342023 @default.
• W2052416034 crossrefType "journal-article" @default.
• W2052416034 hasAuthorship W2052416034A5003137410 @default.
• W2052416034 hasAuthorship W2052416034A5004594453 @default.
• W2052416034 hasAuthorship W2052416034A5009100151 @default.
• W2052416034 hasAuthorship W2052416034A5047943045 @default.
• W2052416034 hasAuthorship W2052416034A5059360959 @default.
• W2052416034 hasAuthorship W2052416034A5081632497 @default.
• W2052416034 hasAuthorship W2052416034A5083119424 @default.
• W2052416034 hasBestOaLocation W20524160341 @default.
• W2052416034 hasConcept C126322002 @default.
• W2052416034 hasConcept C130287650 @default.
• W2052416034 hasConcept C134018914 @default.
• W2052416034 hasConcept C147708747 @default.
• W2052416034 hasConcept C170493617 @default.
• W2052416034 hasConcept C2775960820 @default.
• W2052416034 hasConcept C2777587049 @default.
• W2052416034 hasConcept C2779338263 @default.
• W2052416034 hasConcept C2780381497 @default.
• W2052416034 hasConcept C49418065 @default.
• W2052416034 hasConcept C50044444 @default.
• W2052416034 hasConcept C502942594 @default.
• W2052416034 hasConcept C54355233 @default.
• W2052416034 hasConcept C66400584 @default.
• W2052416034 hasConcept C71924100 @default.
• W2052416034 hasConcept C74373430 @default.
• W2052416034 hasConcept C81885089 @default.
• W2052416034 hasConcept C82867764 @default.
• W2052416034 hasConcept C86803240 @default.
• W2052416034 hasConceptScore W2052416034C126322002 @default.
• W2052416034 hasConceptScore W2052416034C130287650 @default.
• W2052416034 hasConceptScore W2052416034C134018914 @default.
• W2052416034 hasConceptScore W2052416034C147708747 @default.
• W2052416034 hasConceptScore W2052416034C170493617 @default.
• W2052416034 hasConceptScore W2052416034C2775960820 @default.
• W2052416034 hasConceptScore W2052416034C2777587049 @default.
• W2052416034 hasConceptScore W2052416034C2779338263 @default.
• W2052416034 hasConceptScore W2052416034C2780381497 @default.
• W2052416034 hasConceptScore W2052416034C49418065 @default.
• W2052416034 hasConceptScore W2052416034C50044444 @default.
• W2052416034 hasConceptScore W2052416034C502942594 @default.
• W2052416034 hasConceptScore W2052416034C54355233 @default.
• W2052416034 hasConceptScore W2052416034C66400584 @default.
• W2052416034 hasConceptScore W2052416034C71924100 @default.
• W2052416034 hasConceptScore W2052416034C74373430 @default.
• W2052416034 hasConceptScore W2052416034C81885089 @default.
• W2052416034 hasConceptScore W2052416034C82867764 @default.
• W2052416034 hasConceptScore W2052416034C86803240 @default.
• W2052416034 hasIssue "11" @default.
• W2052416034 hasLocation W20524160341 @default.
• W2052416034 hasLocation W20524160342 @default.

• next